July 7 Practice & Trends On The Cover Pharmacists embrace telehealth during COVID-19 PT August 2020 When the COVID-19 pandemic upended nearly every aspect of people’s lives this year, telehealth allowed patients to continue to access health care. Loren BonnerLoren BonnerLoren Bonner
July 7 Practice & Trends Policy Roundup Getting ready for the next pandemic, PBMs in court, and more PT August 2020 Life moves fast. Here’s a roundup of a few of the most important policy developments to help you keep up. Rachel Balick
July 7 Practice & Trends Mental Health Pharmacists’ role in mental health expands during COVID-19 PT August 2020 The fragility of our mental health has never been more exposed than during the COVID-19 pandemic. Loren Bonner
July 7 Practice & Trends Flu Vaccines What we do and don’t know about flu in the COVID-19 era PT August 2020 On July 6, a member of the Pharmacy Staff for COVID-19 Support Facebook community posed a question to their peers: “What is your prediction for this coming flu vaccination season?” Rachel Balick
July 7 Practice & Trends Error Alert Avoiding methadone dosing problems PT August 2020 Methadone overdose has been linked to mistaken use of concentrated oral solution and scanning the wrong barcode. Institute for Safe Medication Practices, Horsham, PA
July 7 Association Perspective Association Perspective Chaotic reimbursement models put patients at risk PT August 2020 The last thing that pharmacists want to do is harm a patient. Scott J. Knoer, MS, PharmD, FASHP, APhA EVP and CEO
July 7 Today's Perspective Today's Perspective COVID-19 as a catalyst for change PT August 2020 Some days it seems as if everything about our world has shifted in the era of COVID-19. Kristin Wiisanen, PharmD, FAPhA, FCCP, Pharmacy Today editor in chief
July 7 Bulletin Today Bulletin Today Pharmacy organizations take a stand against racial injustice PT August 2020 Fourteen national pharmacy associations, including APhA, have signed onto a joint statement against racial injustice.
July 7 Drugs & Diseases Abnormal Clotting Patients with COVID-19 may experience abnormal clotting PT August 2020 Various researchers have noted abnormal blood clotting among patients diagnosed with COVID-19. Charnicia Huggins, PharmD
July 7 Drugs & Diseases COVID-19 Scams Crooks are using COVID-19 to scam patients PT August 2020 Illegitimate online pharmacies aren’t new. Rachel Balick
July 7 Drugs & Diseases On The Shelf COVID-19 ‘alternative’ treatments PT August 2020 Recently, the National Center for Complementary and Integrative Health (NCCIH), a division of the National Institutes of Health, warned against the use of “alternative treatments” for COVID-19. Aina Abell
July 7 Drugs & Diseases OTCs Today Ear disorders PT August 2020 Ear disorders affect pediatric and geriatric patients with greater frequency than other patients. Daniel L. Krinsky, RPh, MS
July 7 Drugs & Diseases New Drug Treatment approved for heavy menstrual bleeding associated with fibroids PT August 2020 Oriahnn (AbbVie) is the first and only FDA-approved oral treatment for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. Maria G. Tanzi, PharmD
July 7 Health Systems Trending Topics in Health-System Pharmacy Inpatient Insights PT August 2020 Trending Topics in Health-System Pharmacy
July 7 Health Systems Heart Failure Dapagliflozin approved as new heart failure treatment PT August 2020 In May, FDA approved dapagliflozin to treat patients with New York Heart Association (NYHA) class II–IV heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization. Joey Sweeney, PharmD, BCPS
July 7 Health Systems Superinfections Considering superinfections and antimicrobial resistance during COVID-19 PT August 2020 Superinfections—infections that occur alongside another infection—are often present in patients who have died from COVID-19. Joey Sweeney, PharmD, BCPS
July 7 Health Systems ISMP Alerts ISMP updates: Remdesivir, propofol, and vincristine PT August 2020 Over the past few months the Institute for Safe Medication Practices (ISMP) has released information on a compounding error that occurred with the investigational use of remdesivir for the management of COVID-19 patients, the potential for overdoses with a 2% propofol product recently approved by FDA for emergency use, and updated vincristine labeling and packaging. Maria G. Tanzi, PharmD
July 7 CPE CPE To CBD or not to CBD?: What pharmacists need to know PT August 2020 Today’s pharmacists face both a clinical and ethical dilemma surrounding the medical use of a DEA Schedule I drug: marijuana, or specifically, one of its components, cannabidiol (CBD). Merrill Norton, PharmD, DPh, ICCDP-D
July 7 Crossword Challenge Crossword Challenge Crossword Challenge: Test Your Knowledge! PT August 2020 Take the Crossword Challenge
July 7 Today's Pharmacist Provider Status Profile Pharmacist in FQHC solves mystery of chronic UTIs and uncontrolled diabetes PT August 2020 “Shirley” visited the urgent care clinic at Caring Health, a federally qualified health center (FQHC) in Springfield, MA, almost monthly for UTIs. Sonya Collins
July 7 Today's Pharmacist On The Docket Pharmacist testifies in a physician malpractice lawsuit PT August 2020 The standard of care in a medical malpractice lawsuit is usually established through expert witness testimony by clinicians who have extensive experience in the same specialty (or subspecialty) field as the defendant. David B. Brushwood, BSPharm, JD